Haindl, MT; Vershinin, V; Ferstl-Rohrbacher, A; Keck, T; Gugatschka, M; Wolfsberger, S; Khalil, M; Enzinger, C; Hochmeister, S
Laboratory diagnostics of rhinoliquorrhea – re-evaluation of cut-off values of beta-trace protein
11th Congress of the European Academy of Neurology (EAN); June 21-24, 2025; Helsinki, FINLAND. 2025.
[Oral Communication]
FullText
Hochmeister, S; Pichler, A; Archelos JJ
Zerebrale Vaskulitis als schwere Komplikation von akuten Meningoencephalitiden
Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN) 2024; MAR 13-15, 2024; Vienna, AUSTRIA. 2024.
[Poster]
FullText
Damulina, A; Pirpamer, L; Demjaha, R; Tafrali, C; Wurth, S; Heschl, B; Hochmeister, S; Garcia, JJA; Opriessnig, P; Ropele, S; Enzinger, C; Khalil, M
Intrathecal kappa free light chains indicate higher MRI lesion burden in patients with multiple sclerosis
MULT SCLER J. 2023; 29: 565-565.
[Poster]
Web of Science
FullText
Weiss, B; Pichler, A; Damulina, A; Seifert-Held, T; Enzinger, C; Archelos-Garcia, J; Khalil, M
Cerebrospinal fluid kappa free light chains in patients with an isolated band in isoelectric focusing
EUR J NEUROL. 2022; 29: 301-301.
[Poster]
Web of Science
Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, J-J; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Abstract book 2nd Meeting of the Society for CSF analysis and clinical neurochemistry. 2018; 73-73.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS.
[Poster]
FullText
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Neurologisch. 2018; 2018(S1):61-61.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA.
[Poster]
FullText
Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Web of Science
FullText
Voortman, MM; Pekar, T; Bachmayer D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
The role of serum netrin-1 in early multiple sclerosis.
Neurologisch. 2017; 2017(S2):50-51.-14. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Mar 22-24, 2017; Villach, Austria; MAR 22-24, 2017; Villach, AUSTRIA.
[Oral Communication]
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Doctoral day of the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM.
[Poster]
Web of Science
Voortman, MM; Bachmayer, D; Pekar, T; Seifert-Held, T; Archelos, J-J; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
The role of serum Netrin-1 in early multiple sclerosis.
Doctoral day Medical University of Graz; DEC 14, 2016; Graz, AUSTRIA. 2016.
[Oral Communication]
Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
Multiple Sclerosis Journal. 2016; 22(S3):274-274.-32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM.
[Poster]
FullText
Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
The role of serum Netrin-1 in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
FullText
Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
FullText
Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F.
Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
http://www.eaneurology.org/berlin2015/. 2015; -1st Congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY.
[Oral Communication]
Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F.
Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation.
Neurologisch, Supplementum 2/2015. 2015; 2015(2):23-23.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA.
[Poster]
Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY.
[Poster]
Web of Science
Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Stojakovic, T; Voortman, MM; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Hematology Reports. 2015; 7(S1):67-67.-7th International Symposium on Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis; APR 16-17, 2015; Edinburgh, UNITED KINGDOM.
[Poster]
Voortman, M M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M.
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. 2015.
[Poster]
Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY.
[Poster]
Web of Science
Voortman, M.M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J.J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Eur J Neurol. 2015; 22(S1):398-398.-1st Congress of the European Academy of Neurology (EAN); JUN 20-23, 2015; Berlin, GERMANY.
[Poster]
Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Poster]
Web of Science
Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Neurologisch, Supplementum 2/2015. 2015; 2: 25-25.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27, 2015; Graz, AUSTRIA.
[Poster]
Voortman, MM; Stojakovic, T;Jehna, M;Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Multiple Sclerosis Journal. 2015; 21(S11):630-630.-31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 7-10, 2015; Barcelona, SPAIN.
[Poster]
FullText
Khalil, M; Renner, A; Langkammer, C; Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F
Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
NCA NUBIN 2014 Symposium - The 5th biannual symposium on body fluid biomarkers for inflammation and neurodegeneration.; October 29-30, 2014; Amsterdam, THE NETHERLANDS. 2014.
[Oral Communication]
Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545.
[Poster]
Web of Science
Khalil, M; Riedlbauer, B;Langkammer, C;Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, J.J; Fuchs, S; Fazekas, F
Cerebrospinal fluid (CSF) transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurology. 2013; 260, Supplement 1: 39-40.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11, 2013; Barcelona, SPAIN.
[Oral Communication]
Patz, S; Trattnig, C; Absenger M; Wissa, S; Archelos-Garcia, J; Schäfer, U
Delivery of RNA cargo by microparticles to NTera-2 cells induces changes in the expression pattern of cellular mRNAs.
J Neurol Neurochir Psychiatr. 2013; 14 (Sonderheft 1): 22-22.-Abstracts, 49. Jahrestagung der Österreichischen Gesellschaft für Neurochirurgie; OCT 10-12, 2013; Innsbruck, AUSTRIA.
[Oral Communication]
Patz, S; Trattnig, C; Grunbacher, G; Gully, C; Leitinger, G; Absenger, M; Tomescu, OA; Fasching, U; Archelos-Garcia, J; Schafer, U
miR-451 REGULATES THE INDUCTION OF EARLY NEUROGENIC PROCESSES, PARTICULARLY, CELL POLARITY AND MIGRATION DURING THE ACUTE PHASE OF TBI
SHOCK. . 2013; 40: 26-26.-5th Congress of the European-Shock-Society (ESS); SEP 12-14, 2013; Vienna, AUSTRIA.
[Poster]
Web of Science
Patz, S, Trattnig, C, Grünbacher, G, Leitinger, G, Absenger, M, Tomescu, OA, Fasching, U, Archelos-Garcia, J, Schäfer, U
miR-451 regulates the induction of early neurogenetic processes, particularly cell polarity and migration during the acute phase of TBI
15th Congress of the European Shock Society; SEP 12-14, 2013; Vienna, AUSTRIA. 2013.
[Oral Communication]
Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Archelos, JJ;
Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE.
CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz, AUSTRIA. 2012.
[Poster]
Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE
CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis.
Proceedings. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 10-13, 2012; Lyon, FRANCE.
[Poster]
Mader, A; Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Archelos, JJ;
Blankenstein, MA; Fuchs, S;Fazekas, F; Teunissen, CE.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012 ; Graz, AUSTRIA. 2012.
[Poster]
Wutte, N; Fazekas, F; Zenz, W; Archelos, J; Aberer, E
Is there a need for Immunoblot testing in the CSF in Lyme Neuroborreliosis?
OEGN Jahrestagung 2012; Graz, Austria. 2012.
[Poster]
Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Vane, M; Trentini, A; Wallner-Blazek, M; Archelos, JJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE
CSF neurofilaments and N-acetylaspartate in relation to MRI-metrics at 3T in clinically isolated syndromes suggestive of multiple sclerosis
Multiple Sclerosis Journal (Formerly Multiple Sclerosis). 2011; 17(S10):S266--5th Joint Triennial Congress of ECTRIMS and ACTRIMS; OCT 1922, 2011 ; Amsterdam, The NETHERLANDS.
[Poster]
Patz, S; Trattnig, C; Absenger, M; Wissa, S; Archelos-Garcia, J; Schäfer, U
Delivery of RNA cargo by microparticles to NTera-2 cells induces changes in the expression pattern of cellular mRNAs.
Abstracts of the 12th Annual Meeting of the Austrian Neuroscience Association (ANA), Seite 54. 2011; SEP 19-21, 2011; Alpbach, AUSTRIA.
[Poster]
Simmet, N; Pendl, B; Enzinger, C; Gattringer, T; Pichler, A; Zechner, B; Archelos, J; Fazekas F
Koinzidenz von progressiver multifokaler Leukenzephalopathie (PML) und pulmonaler Sarkoidose.
neurologisch (Supplementum)2011; 1/2011: 36-37.-9. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, AUSTRIA.
[Poster]
Simmet, N; Pendl, B; Enzinger, C; Gattringer, T; Pichler, A; Zechner, B; Archelos, J; Haybaeck, J; Scarpatetti, M; Fazekas
F
Koinzidenz von progressiver multifokaler Leukenzephalopathie (PML) und pulmonaler Sarkoidose.
11. Austrian Neuroscience Wintermeeting; MAR 31-APR 2, 2011; Kitzbühel, AUSTRIA. 2011.
[Oral Communication]
Simmet, N; Pendl, B; Enzinger, C; Gattringer, T; Pichler, A; Zechner, B; Archelos, J; Haybaeck, J; Scarpatetti, M; Fazekas F
Koinzidenz von progressiver multifokaler Leukenzephalopathie (PML) und pulmonaler Sarkoidose.
Jatros Neurologie & Psychiatrie2011; 2/2011: -11. Austrian Neuroscience Wintermeeting; MAR 31-APR 2, 2011; Kitzbühel, AUSTRIA.
[Poster]
Archelos, J
Immunologische Liquordiagnostik.
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 5-7, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Archelos, J
Neuropädiatrische Aspekte.
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 5-7, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Storch, M; Archelos, J
Neuroimmunologie und Immuntherapie (Programmkoordination)
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 5-7, 2009; Graz, AUSTRIA. 2009.
Neuhaus, O; Manda, VS; Stuve, O; Archelos, JJ; Hartung, H
Mechanisms of statins in multiple sclerosis - Preferential inhibition of activated T lymphocytes by an at least triple mode of action
NEUROLOGY. 2006; 66(5):A176-A176.-American Academy of Neurology 58th Annual Meeting; APR 1-8, 2006; San Diego (CA), USA.
[Oral Communication]
Web of Science
Archelos-Garcia, T; Kaltenböck, F; Baumgartner, A; Mokry, M; Ott, E; Tritthart, H
Liquorunterdrucksyndrom als Ursache eines chronischen beidseitigen Subduralhämatoms.
22. Arbeitstagung für Neurologische Intensiv- und Notfallmedizin (ANIM 2005); JAN 20-22, 2005; Klagenfurt, AUSTRIA. 2005.
[Oral Communication]
Neuhaus, O; Manda, V; Scarpatetti, M; Hoefler, G; Hartung, H; Archelos, J
Tuberculous meningitis - new diagnostic options?
J NEUROL 2005 252: 34-34.
Web of Science
Neuhaus, O; Mando, VS; Stuve, O; Archelos, JJ; Hartung, HP
Mechanisms of statins in multiple sclerosis - inhibition of activated T lymphocytes by dual action: impaired isoprenylation of guanosinetriphosphate-binding proteins and disruption of lipid microdomains
MULT SCLER 2005 11: S166-S166.
Web of Science
Plaisier, E; Mougenot, B; Verpont, MC; Jouanneau, C; Archelos, J; Martini, R; Kerjaschki, D; Ronco, P
Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells
NEPHROL DIALYSIS TRANSPLANT 2005 20: V211-V211.
Web of Science
Neuhaus, O; Stuve, O; Archelos, JJ; Hartung, HP
Putative mechanisms of statins in multiple sclerosis - preferential inhibition of activated T lymphocytes
J NEUROIMMUNOL 2004 154: 226-226.
Web of Science
Krametter, DF; Stuenzner, D; Gruber-Sedlmayr, U; Weishaupt, A; Hartung, HP; Archelos, JJ
Epitope-specific humoral immune response to myelin protein zero (PO) in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
NEUROLOGY 2002 58: A230-A231.
Web of Science
Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Hartung, HP; Archelos, JJ
Multiple sclerosis: Immunologic effects of statins in vitro: A new therapeutic approach?
NEUROLOGY 2002 58: A73-A73.
Web of Science
Niederwieser, G; Buchinger, W; Bonelli, RM; Berghold, A; Reisecker, F; Archelos, JJ; Koltringer, P
Prevalence of thyroid disease in multiple sclerosis
FASEB J 2001 15: A73-A73.
Web of Science
Vallat, JM; Sindou, P; Chapan, F; Archelos, JJ; Tabaraud, F; Braund, KG; Maisonobe, T; Haun, JJ; Vandenberghe, A
Ultrastructural quantification of PO immunoreactivity on biopsied sural nerves from patients with Charcot-Marie-Tooth disease type 1B
ANN NEUROL 1997 42: M96-M96.
Web of Science
HARTUNG, HP; ARCHELOS, JJ; JUNG, S; MIYASAKA, M; TOYKA, KV
INHIBITION OF EXPERIMENTAL AUTOIMMUNE NEURITIS BY MONOCLONAL-ANTIBODIES TO ICAM-1 AND LFA-1
NEUROLOGY. 1993; 43(4): A395-A395.
Web of Science
LANG, RE; RUSKOAHO, H; THOLKEN, H; ARCHELOS, J; GANTEN, D; UNGER, T
REGULATION OF RELEASE OF ATRIAL NATRIURETIC HORMONES
J HYPERTENSION. 1985; 3: S551-S551.
Web of Science
LANG, RE; PETTY, M; ARCHELOS, J; GANTEN, D; HERMANN, K; UNGER, T; XIANG, J
DYNORPHINS ARE NEUROTRANSMITTERS IN CARDIAC SYMPATHETIC-NERVES
HYPERTENSION. 1984; 6(5): 787-787.
Web of Science